These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¨
|
Preliminary Proxy Statement
|
|
|
|
|
|
|
¨
|
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
|
|
|
|
þ
|
Definitive Proxy Statement
|
|
|
|
|
|
|
¨
|
Definitive Additional Materials
|
|
|
|
|
|
|
¨
|
Soliciting Material Pursuant to 240.14a-12
|
|
|
|
||
|
iRobot Corporation
|
||
|
(Name of Registrant as Specified in Its Charter)
|
||
|
|
||
|
|
||
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
||
|
|
||
|
Payment of Filing Fee (Check the appropriate box):
|
||
|
|
|
|
|
þ
|
No fee required.
|
|
|
|
|
|
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
|
|
5)
|
Total fee paid:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¨
|
Fee paid previously with preliminary materials.
|
|
|
|
|
|
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
|
|
1)
|
Amount previously paid:
|
|
|
|
|
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
|
|
3)
|
Filing Party:
|
|
|
|
|
|
|
4)
|
Date Filed:
|
|
|
|
|
|
|
|
|
Dear Stockholder:
|
April 9, 2014
|
|
•
|
Majority Voting Standard for Election of Directors
. The board of directors has amended our by-laws to provide that, in uncontested director elections, a director nominee will be elected only if the votes cast for such nominee’s election exceed the votes cast against such nominee’s election.
|
|
•
|
Termination of Rights Plan
. The board of directors has amended its rights plan - commonly known as a “poison pill” - to accelerate its termination from November 2015 to April 2014.
|
|
Annual "say-on-pay" vote
|
|
No pension benefits for executive officers
|
|
Oversight of risks associated with compensation policies and practice
|
|
No discounted options
|
|
Strong stock ownership and stock holding guidelines
|
|
No option repricing without shareholder approval
|
|
"Double trigger" change in control agreements
|
|
No excise tax gross-ups
|
|
Independent compensation consultant
|
|
No hedging or pledging of Company stock
|
|
|
|
No excessive perquisites for executives
|
|
|
|
|
PROXY STATEMENT
|
|
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
|
|
|
PROPOSAL 1 — ELECTION OF DIRECTORS
|
|
|
Nominees
|
|
|
Recommendation of the Board
|
|
|
DIRECTORS AND EXECUTIVE OFFICERS
|
|
|
CORPORATE GOVERNANCE AND BOARD MATTERS
|
|
|
Board Leadership Structure
|
|
|
Independence of Members of the Board of Directors
|
|
|
Executive Sessions of Independent Directors
|
|
|
The Board of Directors’ Role in Risk Oversight
|
|
|
Policies Governing Director Nominations
|
|
|
Policy Governing Security Holder Communications with the Board of Directors
|
|
|
Policy Governing Director Attendance at Annual Meetings of Stockholders
|
|
|
Board of Directors Evaluation Program
|
|
|
Code of Ethics
|
|
|
THE BOARD OF DIRECTORS AND ITS COMMITTEES
|
|
|
Board of Directors
|
|
|
Audit Committee
|
|
|
Compensation Committee
|
|
|
Nominating and Corporate Governance Committee
|
|
|
Compensation Committee Interlocks and Insider Participation
|
|
|
REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
|
|
|
REPORT OF THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS
|
|
|
COMPENSATION AND OTHER INFORMATION CONCERNING EXECUTIVE OFFICERS AND DIRECTORS
|
|
|
Compensation Discussion & Analysis
|
|
|
Executive Compensation Summary
|
|
|
Grants of Plan-Based Awards in 2013
|
|
|
Outstanding Equity Awards at Fiscal Year End
|
|
|
Options Exercises and Stock Vested
|
|
|
Potential Benefits Upon Termination or Change in Control
|
|
|
Director Compensation
|
|
|
Transactions with Related Persons
|
|
|
PROPOSAL 2 — RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS
|
|
|
PricewaterhouseCoopers LLP Fees
|
|
|
Recommendation of the Board
|
|
|
PROPOSAL 3 — ADVISORY VOTE ON THE APPROVAL OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS
|
|
|
Recommendation of the Board
|
|
|
PROPOSAL 4 - STOCKHOLDER PROPOSAL ENTITLED "SIMPLE MAJORITY VOTE"
|
|
|
Recommendation of the Board
|
|
|
OTHER MATTERS
|
|
|
STOCKHOLDER PROPOSALS
|
|
|
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
|
|
|
EXPENSES AND SOLICITATION
|
|
|
HOUSEHOLDING OF PROXY MATERIALS
|
|
|
Exhibit A
|
A-1
|
|
|
|
|
|
|
|
Name of Beneficial Owner
|
|
Shares Beneficially
Owned(1) |
|
Percentage of Shares
Beneficially Owned(2) |
|
BlackRock, Inc.(3)
|
|
2,464,280
|
|
8.37%
|
|
40 East 52
nd
St.
New York, NY 10022
|
|
|
|
|
|
The Vanguard Group, Inc.(4)
|
|
1,726,494
|
|
5.87%
|
|
100 Vanguard Boulevard
Malvern, PA 19355
|
|
|
|
|
|
T. Rowe Price Associates, Inc.(5)
|
|
1,545,120
|
|
5.25%
|
|
100 East Pratt Street
Baltimore, MD 21202-1009
|
|
|
|
|
|
Lord, Abbett & Co. LLC(6)
|
|
1,516,482
|
|
5.15%
|
|
90 Hudson Street
Jersey City, NJ 07302-3900
|
|
|
|
|
|
FMR LLC(7)
|
|
1,498,907
|
|
5.09%
|
|
245 Summer Street
Boston, MA 02210
|
|
|
|
|
|
Colin M. Angle(8)
|
|
661,044
|
|
2.22%
|
|
Alison Dean(9)
|
|
35,565
|
|
*
|
|
Russell J. Campanello(10)
|
|
62,025
|
|
*
|
|
Paolo Pirjanian (11)
|
|
35,109
|
|
*
|
|
Glen D. Weinstein(12)
|
|
57,900
|
|
*
|
|
Ronald Chwang(13)
|
|
257,563
|
|
*
|
|
Gail Deegan(14)
|
|
8,422
|
|
*
|
|
Deborah G. Ellinger(15)
|
|
10,339
|
|
*
|
|
Jacques S. Gansler(16)
|
|
4,572
|
|
*
|
|
Andrea Geisser(17)
|
|
68,902
|
|
*
|
|
George C. McNamee(18)
|
|
163,039
|
|
*
|
|
Paul J. Kern(19)
|
|
79,904
|
|
*
|
|
Paul Sagan(20)
|
|
18,679
|
|
*
|
|
John J. Leahy
|
|
32,349
|
|
*
|
|
Jeffrey A. Beck
|
|
27,918
|
|
*
|
|
All executive officers, directors and nominees as a group(21) (13 persons)
|
|
1,463,063
|
|
4.86%
|
|
*
|
Represents less than 1% of the outstanding common stock.
|
|
(2)
|
Applicable percentage of ownership as of March 28, 2014 is based upon 29,435,149 shares of common stock outstanding.
|
|
(3)
|
BlackRock Inc. has sole voting power with respect to 2,379,062 shares and sole dispositive power with respect to 2,464,280 shares. This information has been obtained from a Schedule 13G/A filed by BlackRock Inc. with the Securities and Exchange Commission on January 29, 2014.
|
|
(4)
|
The Vanguard Group Inc. has sole voting power with respect to 44,196 shares, sole dispositive power with respect to 1,685,198 shares and shared dispositive power with respect to 41,296 shares. Vanguard Fiduciary Trust Company ("VFTC"), a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 41,296 shares as a result of its serving as investment manager of collective trust accounts. Vanguard Investments Australia, Ltd. ("VIA"), a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 2,900 shares as a result of its serving as investment manager of Australian investment offerings. The address of each reporting entity is 100 Vanguard Boulevard, Malvern, PA 19355. This information has been obtained from a Schedule 13G/A filed by The Vanguard Group, Inc. with the Securities and Exchange Commission on February 11, 2014.
|
|
(5)
|
T. Rowe Price Associates, Inc. has sole voting power with respect to 397,820 shares and sole dispositive power with respect to 1,545,120 shares. This information has been obtained from a Schedule 13G filed by T. Rowe Price Associates, Inc. with the Securities and Exchange Commission on February 12, 2014. The address of T. Rowe Price Associates, Inc. is 100 E. Pratt Street, Baltimore, MD 21202.
|
|
(6)
|
Lord, Abbett & Co. LLC has sole voting power with respect to 1,481,340 shares and sole dispositive power with respect to 1,516,482 shares. This information has been obtained from a Schedule 13G filed by Lord, Abbett & Co. LLC with the Securities and Exchange Commission on February 14, 2014. The address of Lord, Abbett & Co. LLC is 90 Hudson Street, Jersey City, NJ 07302-3900.
|
|
(7)
|
FMR LLC has sole voting power with respect to 320,507 shares. FMR LLC and Edward C. Johnson 3d each have sole dispositive power with respect to 1,178,400 shares. Fidelity Management & Research Company (“Fidelity”), a wholly owned subsidiary of FMR LLC and an investment adviser, is a beneficial owner of 1,178,400 shares. Crosby Advisors LLC, a wholly-owned subsidiary of Crosby Company of New Hampshire LLC (“CCNH”), is the beneficial owner of 320,169 shares as a result of providing investment advisory services to individuals, trusts and limited liability entities. Members of the family of Edward C. Johnson 3d, Chairman of FMR LLC, directly or indirectly, own CCNH. Neither FMR LLC nor Edward C. Johnson 3d has the sole power to vote or direct the voting of the shares owned directly by the Fidelity Funds, which power resides with the Funds’ Boards of Trustees. Fidelity carries out the voting of the shares under written guidelines established by the Funds’ Boards of Trustees. The address of each reporting entity is 245 Summer St., Boston, MA 02210. This information has been obtained from a Schedule 13G filed by FMR LLC and Edward C. Johnson 3d with the Securities and Exchange Commission on February 10, 2014.
|
|
(8)
|
Includes 277,136 shares issuable to Mr. Angle upon exercise of stock options and 13,262 shares issuable to Mr. Angle upon vesting of restricted stock units.
|
|
(9)
|
Includes 22,012 shares issuable to Ms. Dean upon exercise of stock options and 1,656 shares issuable to Ms. Dean upon vesting of restricted stock units.
|
|
(10)
|
Includes 35,613 shares issuable to Mr. Campanello upon exercise of stock options.
|
|
(11)
|
Includes 33,220 shares issuable to Dr. Pirjanian upon exercise of stock options.
|
|
(12)
|
Includes 26,444 shares issuable to Mr. Weinstein upon exercise of stock options and 3,012 shares issuable to Mr. Weinstein upon vesting of restricted stock units.
|
|
(13)
|
Includes an aggregate of 140,000 shares held by iD5 Fund, L.P. Dr. Chwang is a general partner of the management company for iD5 Fund, L.P. and may be deemed to share voting and investment power with respect to all shares held by iD5 Fund, L.P. Dr. Chwang disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any. Also includes 30,000 shares issuable to Dr. Chwang upon exercise of stock options, 3,172 shares issuable to Dr. Chwang upon vesting of restricted stock options and 79,210 shares held in a trust for the benefit of certain of his family members. As co-trustees of the family trust, Dr. Chwang shares voting and dispositive power over the shares held by the trust with his spouse.
|
|
(14)
|
Includes 3,172 shares issuable to Ms. Deegan upon vesting of restricted stock units.
|
|
(15)
|
Includes 3,172 shares issuable to Ms. Ellinger upon vesting of restricted stock units.
|
|
(16)
|
Includes 3,172 shares issuable to Dr. Gansler upon vesting of restricted stock units.
|
|
(17)
|
Includes 40,000 shares issuable to Mr. Geisser upon exercise of stock options, 3,172 shares issuable to Mr. Geisser upon vesting of restricted stock units and 12,643 shares issuable to Mr. Geisser upon termination of service.
|
|
(18)
|
Includes 80,000 shares issuable to Mr. McNamee upon exercise of stock options, 3,172 shares issuable to Mr. McNamee upon vesting of restricted stock units and 3,487 shares issuable to Mr. McNamee upon termination of service.
|
|
(19)
|
Includes 60,000 shares issuable to Gen. Kern upon exercise of stock options, 3,172 shares issuable to Gen. Kern upon vesting of restricted stock units and 8,492 shares issuable to Gen. Kern upon termination of service.
|
|
(20)
|
Includes 2,500 shares issuable to Mr. Sagan upon exercise of stock options, 3,172 shares issuable to Mr. Sagan upon vesting of restricted stock units and 5,015 shares issuable to Mr. Sagan upon termination of service.
|
|
(21)
|
Includes an aggregate of 606,925 shares issuable upon exercise of stock options held by ten (10) executive officers and directors, an aggregate of 43,306 shares issuable upon vesting of restricted stock units held by eleven (11) executive officers and directors and an aggregate of 29,637 shares issuable upon termination of service to four (4) directors.
|
|
|
|
|
|
|
|
|
|
Nominee’s or Director’s Name and
Year First Became a Director
|
|
Position(s) with the Company
|
|
Year Current Term Will Expire
|
|
Current Class of Director
|
|
Nominees for Class III Directors:
|
|
|
|
|
|
|
|
Gail Deegan
2011
|
|
Director
|
|
2014
|
|
III
|
|
Andrea Geisser
2004
|
|
Director
|
|
2014
|
|
III
|
|
Continuing Directors:
|
|
|
|
|
|
|
|
Colin M. Angle
1992
|
|
Chairman of the Board, Chief Executive Officer and Director
|
|
2015
|
|
I
|
|
Ronald Chwang, Ph.D.
1998
|
|
Director
|
|
2015
|
|
I
|
|
Paul J. Kern, Gen. U.S. Army (ret.)
2006
|
|
Director
|
|
2015
|
|
I
|
|
Deborah G. Ellinger
2011 |
|
Director
|
|
2015
|
|
I
|
|
George C. McNamee
1999
|
|
Director
|
|
2016
|
|
II
|
|
Paul Sagan
2010
|
|
Director
|
|
2016
|
|
II
|
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
|
Colin M. Angle
|
|
46
|
|
Chairman of the Board, Chief Executive Officer and Director
|
|
Alison Dean
|
|
49
|
|
Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer
|
|
Russell J. Campanello
|
|
58
|
|
Executive Vice President, Human Resources
|
|
Paolo Pirjanian, Ph.D.
|
|
46
|
|
Executive Vice President, Chief Technology Officer
|
|
Glen D. Weinstein
|
|
43
|
|
Executive Vice President, Chief Legal Officer
|
|
Ronald Chwang, Ph.D.(1)
|
|
66
|
|
Director
|
|
Gail Deegan(2)
|
|
67
|
|
Director
|
|
Deborah G. Ellinger(1)
|
|
55
|
|
Director
|
|
Jacques S. Gansler, Ph.D.(3)
|
|
79
|
|
Director
|
|
Andrea Geisser(2)
|
|
71
|
|
Director
|
|
George C. McNamee(1)(3)
|
|
67
|
|
Director
|
|
Paul J. Kern, Gen. U.S. Army (ret)(2)
|
|
68
|
|
Director
|
|
Paul Sagan(3)
|
|
55
|
|
Director
|
|
(1)
|
Member of compensation committee
|
|
(2)
|
Member of audit committee
|
|
(3)
|
Member of nominating and corporate governance committee
|
|
•
|
providing the chairman of the board with input as to preparation of agendas for meetings;
|
|
•
|
advising the chairman of the board as to the quality, quantity and timeliness of the flow of information from the Company’s management that is necessary for the independent directors to effectively and responsibly perform their duties;
|
|
•
|
coordinating and developing the agenda for the executive sessions of the independent directors;
|
|
•
|
acting as principal liaison between the independent directors and the chairman of the board on sensitive issues;
|
|
•
|
evaluating, along with the members of the compensation committee, the chief executive officer’s performance and meeting with the chief executive officer to discuss such evaluation; and
|
|
•
|
acting as chairperson of the board in the absence of the chairman of the board or a vacancy in the position of chairman of the board.
|
|
•
|
nominees must have experience at a strategic or policy making level in a business, government, non-profit or academic organization of high standing;
|
|
•
|
nominees must be highly accomplished in his or her respective field, with superior credentials and recognition;
|
|
•
|
nominees must be well regarded in the community and shall have a long-term reputation for the highest ethical and moral standards;
|
|
•
|
nominees must have sufficient time and availability to devote to the affairs of the Company, particularly in light of the number of boards on which the nominee may serve;
|
|
•
|
nominees must be free of conflicts of interest and potential conflicts of interest, in particular with relationships with other boards; and
|
|
•
|
nominees must, to the extent such nominee serves or has previously served on other boards, demonstrate a history of actively contributing at board meetings.
|
|
•
|
Name and address of the stockholder making the recommendation, as they appear on our books and records, and of such record holder’s beneficial owner;
|
|
•
|
Number of shares of our capital stock that are owned beneficially and held of record by such stockholder and such beneficial owner;
|
|
•
|
Name, age, business and residential address, educational background, current principal occupation or employment, and principal occupation or employment for the preceding five full fiscal years of the individual recommended for consideration as a director nominee;
|
|
•
|
All other information relating to the recommended candidate that would be required to be disclosed in solicitations of proxies for the election of directors or is otherwise required, in each case pursuant to Regulation 14A under the Exchange Act, including the recommended candidate’s written consent to being named in the proxy statement as a nominee and to serving as a director if approved by the board of directors and elected; and
|
|
•
|
A written statement from the stockholder making the recommendation stating why such recommended candidate meets our criteria and would be able to fulfill the duties of a director.
|
|
•
|
appointing, approving the compensation of, and assessing the independence of our independent registered public accounting firm;
|
|
•
|
pre-approving auditing and permissible non-audit services, and the terms of such services, to be provided by our independent registered public accounting firm;
|
|
•
|
reviewing and discussing with management and the independent registered public accounting firm our annual and quarterly financial statements and related disclosures;
|
|
•
|
coordinating the oversight and reviewing the adequacy of our internal control over financial reporting;
|
|
•
|
overseeing the performance of our internal auditors and internal audit functions, including reviewing the annual internal audit risk assessment as well as the scope of, and overall plans for, the annual internal audit program;
|
|
•
|
establishing policies and procedures for the receipt and retention of accounting related complaints and concerns;
|
|
•
|
reviewing and discussing with management risk assessment and risk management, including cyber security;
|
|
•
|
overseeing the development of business continuity plans;
|
|
•
|
overseeing our compliance with certain legal and regulatory requirements including, but not limited to, the Foreign Corrupt Practices Act;
|
|
•
|
preparing the audit committee report required by SEC rules to be included in our annual proxy statement: and
|
|
•
|
such other matters as the committee deems appropriate.
|
|
•
|
annually reviewing and approving corporate goals and objectives relevant to compensation of our chief executive officer and other executive officers;
|
|
•
|
evaluating the performance of our chief executive officer in light of such corporate goals and objectives and determining the compensation of our chief executive officer and other executive officers;
|
|
•
|
overseeing and administering our compensation, welfare, benefit and pension plans and similar plans and determining the compensation of all executive officers; and
|
|
•
|
reviewing and making recommendations to the board with respect to director compensation.
|
|
•
|
developing and recommending to the board criteria for board and committee membership;
|
|
•
|
establishing procedures for identifying and evaluating director candidates including nominees recommended by stockholders;
|
|
•
|
identifying individuals qualified to become board members;
|
|
•
|
recommending to the board the persons to be nominated for election as directors and to each of the board’s committees;
|
|
•
|
developing and recommending to the board a code of business conduct and ethics and a set of corporate governance guidelines; and
|
|
•
|
overseeing the evaluation of the board and management.
|
|
•
|
Provide competitive compensation that attracts, motivates and retains the best talent and the highest caliber executives to help us to achieve our strategic objectives;
|
|
•
|
Connect a significant portion of the total potential compensation paid to executives to our annual financial performance;
|
|
•
|
Align management's interest with the interests of stockholders through long-term equity incentives; and
|
|
•
|
Provide management with performance goals directly linked to our annual plan for growth and profit.
|
|
For
|
17,851,593
|
|
92.64
|
%
|
|
Against
|
1,371,142
|
|
7.11
|
%
|
|
Abstain
|
45,606
|
|
0.24
|
%
|
|
For
|
11,448,782
|
|
59.55
|
%
|
|
Against
|
7,646,078
|
|
39.77
|
%
|
|
Abstain
|
129,742
|
|
0.68
|
%
|
|
•
|
Companies with revenues within a similar range and generally similar market capitalization;
|
|
•
|
Companies within comparable industries that focus on high-tech products (e.g., information technology, consumer durables, consumer services, aerospace/defense, capital goods, electronics equipment, instruments and components, healthcare technology, etc.);
|
|
•
|
Companies with highly-engineered products and complex technologies with multiple industry applications;
|
|
•
|
Technology companies whose products contain both hardware and software components; and
|
|
•
|
Companies with moderate to high sales growth and opportunity.
|
|
•
|
Other criteria also considered include:
|
|
•
|
Companies classified as “disruptive innovation;”
|
|
•
|
Companies with products with brand recognition and/or disposable income “luxury” goods; and
|
|
•
|
Companies with moderate margins and levels of research and development expense.
|
|
Accuray Incorporated
|
Orbital Sciences Corporation
|
|
AeroVironment, Inc.
|
Plantronics, Inc.
|
|
American Science and Engineering, Inc.
|
SeaChange International, Inc.
|
|
Bruker Corporation
|
Synaptics Incorporated
|
|
Cognex Corporation
|
Tivo, Inc.
|
|
Leapfrog Enterprises, Inc.
|
Universal Electronics, Inc.
|
|
Mercury Systems, Inc.
|
Voxx International Corp.
|
|
Netgear, Inc.
|
|
|
•
|
the scope and strategic impact of the executive officer's responsibilities,
|
|
•
|
our past business and segment performance, and future expectations,
|
|
•
|
our long-term goals and strategies,
|
|
•
|
the performance and experience of each individual,
|
|
•
|
past compensation levels of each individual and of the named executive officers as a group,
|
|
•
|
relative levels of pay among the executive officers,
|
|
•
|
the amount of each component of compensation in the context of the executive officer's total compensation and other benefits,
|
|
•
|
for each named executive officer, other than the chief executive officer, the evaluations and recommendations of the chief executive officer, and
|
|
•
|
the competitiveness of the compensation packages relative to the selected benchmarks as highlighted by the independent compensation consultant's analysis.
|
|
|
|
2012 Base Salary
|
|
% Increase
|
|
2013 Base Salary
|
|
% Increase
|
|
2014 Base Salary
|
|
Colin M. Angle
|
|
$525,000
|
|
19.0%
|
|
$625,000
|
|
4.0%
|
|
$650,000
|
|
Alison Dean
|
|
$249,930
|
|
30.0%
|
|
$325,000
|
|
23.1%
|
|
$400,000
|
|
Russell J. Campanello
|
|
$300,000
|
|
8.3%
|
|
$325,000
|
|
0.0%
|
|
$325,000
|
|
Paolo Pirjanian
|
|
$278,250
|
|
16.8%
|
|
$325,000
|
|
7.7%
|
|
$350,000
|
|
Glen D. Weinstein
|
|
$325,000
|
|
3.1%
|
|
$335,000
|
|
4.0%
|
|
$348,500
|
|
John J. Leahy
|
|
$375,000
|
|
14.7%
|
|
$430,000
|
|
N/A
|
|
N/A
|
|
Jeffrey A. Beck
|
|
$410,000
|
|
4.9%
|
|
$430,000
|
|
N/A
|
|
N/A
|
|
|
Incentive Bonus Award Opportunity Payout Scale (% of base salary)
|
||||
|
|
Threshold
(35% of target opportunity) (1)
|
|
Target (100%)
|
|
Maximum
(190% of target opportunity) (2)
|
|
Colin M. Angle
|
35.00%
|
|
100%
|
|
190.00%
|
|
Alison Dean
|
21.00%
|
|
60%
|
|
114.00%
|
|
Russell J. Campanello
|
21.00%
|
|
60%
|
|
114.00%
|
|
Paolo Pirjanian
|
21.00%
|
|
60%
|
|
114.00%
|
|
Glen D. Weinstein
|
21.00%
|
|
60%
|
|
114.00%
|
|
Jeffrey A. Beck
|
26.25%
|
|
75%
|
|
142.50%
|
|
(1)
|
Threshold payments are made only after the Company has achieved certain Adjusted EBITDA, excluding cash incentive compensation expense.
|
|
(2)
|
This reflects the maximum incentive cash payout levels established under our Senior Executive Incentive Compensation Plan for 2013 based on the specific targets established for fiscal 2013.
|
|
Performance Measure
|
|
Weighting
|
|
Performance Goal
|
||||
|
|
Threshold
|
|
Target
|
|
Maximum
|
|||
|
Adjusted EBITDA, excluding cash incentive compensation expense
|
|
70%
|
|
$53.2 million
|
|
$59.1 million
|
|
$76.8 million
|
|
Revenue
|
|
30%
|
|
$391.5 million
|
|
$489.4 million
|
|
$636.2 million
|
|
Metric
|
|
Minimum
|
|
Target
(100%)
|
|
Maximum
|
|
2013 Actual
Performance
|
|
Actual
Percentage
Earned (as %
of target)
|
|
|
|
$ in millions
|
|
|
||||||
|
Adjusted EBITDA, excluding cash incentive compensation expense
|
|
$53.2
|
|
$59.1
|
|
$76.8
|
|
$75.3
|
|
182%
|
|
Company Revenue
|
|
$391.5
|
|
$489.4
|
|
$636.2
|
|
$487.4
|
|
98%
|
|
|
|
Incentive Bonus Award
|
||||
|
Original Target Incentive
Opportunity
|
|
Achievement
|
|
ICP Earned
|
||
|
Colin M. Angle
|
|
$625,000
|
|
157%
|
|
$981,250
|
|
Alison Dean
|
|
$195,000
|
|
157%
|
|
$306,150
|
|
Glen D. Weinstein
|
|
$201,000
|
|
157%
|
|
$315,570
|
|
Russell J. Campanello
|
|
$195,000
|
|
157%
|
|
$306,150
|
|
Paolo Pirjanian
|
|
$195,000
|
|
157%
|
|
$306,150
|
|
John J. Leahy(1)
|
|
$—
|
|
—%
|
|
$—
|
|
Jeffrey A. Beck (2)
|
|
$322,500
|
|
157%
|
|
$506,325
|
|
(1)
|
Mr. Leahy retired from the Company on April 5, 2013 and therefore was ineligible to receive a bonus under the Senior Executive Incentive Compensation Plan for 2013.
|
|
(2)
|
Mr. Beck's ICP Earned represents a cash payment, pursuant to a Separation Agreement dated November 25, 2013 between the Company and Mr. Beck, in an amount equal to what he would have received as a bonus for fiscal 2013 under the Company's Senior Executive Incentive Compensation Plan had his employment continued until the bonus payments were made to the other named executive officers under the Senior Executive Incentive Compensation Plan.
|
|
•
|
Alignment with business strategy;
|
|
•
|
Alignment with stockholder interest in improving long-term business fundamentals;
|
|
•
|
Correlation with total stockholder return;
|
|
•
|
Complementary to our short-term incentive metrics;
|
|
•
|
Our compensation program for executive officers is designed to provide a balanced mix of cash and equity and annual and longer-term incentives, including compensation based on the achievement of performance targets.
|
|
•
|
The base salary portion of compensation is designed to provide a steady income regardless of our stock price performance so executives do not feel pressured to focus primarily on stock price performance to the detriment of other important business metrics.
|
|
•
|
Our stock option grants and restricted stock unit grants generally vest over four years and, in the case of stock options, are only valuable if our stock price increases over time.
|
|
•
|
Maximum payout levels for cash incentive compensation are capped.
|
|
•
|
Our stock ownership guidelines align the interests of our executive officers with those of our stockholders.
|
|
•
|
PM&P did not provide any services to us or our management other than service to the compensation committee (including compensation benchmarking for our senior leadership team), and it its services were limited to executive compensation consulting.
|
|
•
|
Fees paid by us to PM&P represented 0.1% of PM&P's total revenue for the period December 2012 through November 2013;
|
|
•
|
PM&P maintains a Conflicts Policy and an Insider Trading Policy which were provided to the compensation committee with specific policies and procedures designed to ensure independence;
|
|
•
|
None of the PM&P consultants on our account had any business or personal relationship with our compensation committee members;
|
|
•
|
None of the PM&P consultants on our account, or PM&P, had any business or personal relationship with our executive officers; and
|
|
•
|
None of the PM&P consultants on our account directly own shares of our stock.
|
|
Name and Principal Position
|
|
Year
|
|
Salary ($)(1)
|
|
Bonus
($) |
|
Stock
Awards ($)(2) |
|
Option
Awards ($)(2) |
|
Non-Equity Incentive Plan Compensation
($)(3) |
|
All Other Compensation
($)(4) |
|
Total
($)
|
|||||||
|
Colin M. Angle
|
|
2013
|
|
613,462
|
|
|
—
|
|
|
1,514,475
|
|
|
379,237
|
|
|
981,250
|
|
|
7,650
|
|
|
3,496,074
|
|
|
Chairman, Chief Executive Officer and Director
|
|
2012
|
|
525,000
|
|
|
105,000
|
|
|
2,160,438
|
|
|
535,742
|
|
|
—
|
|
|
7,500
|
|
|
3,333,680
|
|
|
|
2011
|
|
519,231
|
|
|
—
|
|
|
763,344
|
|
|
754,374
|
|
|
692,158
|
|
|
7,350
|
|
|
2,736,457
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Alison Dean (5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Executive Vice President, Chief Financial Officer and Treasurer
|
|
2013
|
|
308,838
|
|
|
—
|
|
|
721,142
|
|
|
179,783
|
|
|
306,150
|
|
|
7,650
|
|
|
1,523,563
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Russell J. Campanello
|
|
2013
|
|
322,115
|
|
|
—
|
|
|
270,319
|
|
|
67,618
|
|
|
306,150
|
|
|
7,650
|
|
|
973,852
|
|
|
Executive Vice President, Human Resources and Corporate Communications
|
|
2012
|
|
300,000
|
|
|
82,000
|
|
|
557,060
|
|
|
72,176
|
|
|
—
|
|
|
7,500
|
|
|
1,018,736
|
|
|
|
2011
|
|
300,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
200,700
|
|
|
7,350
|
|
|
508,050
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Paolo Pirjanian
|
|
2013
|
|
319,606
|
|
|
—
|
|
|
270,319
|
|
|
67,618
|
|
|
306,150
|
|
|
7,650
|
|
|
971,343
|
|
|
Executive Vice President, Chief Technology Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Glen D. Weinstein
|
|
2013
|
|
333,846
|
|
|
—
|
|
|
270,319
|
|
|
67,618
|
|
|
315,570
|
|
|
7,650
|
|
|
995,003
|
|
|
Executive Vice President and Chief Legal Officer
|
|
2012
|
|
311,289
|
|
|
74,497
|
|
|
593,019
|
|
|
146,916
|
|
|
—
|
|
|
7,500
|
|
|
1,133,221
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
John J. Leahy (6)
|
|
2013
|
|
109,423
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,090
|
|
|
116,513
|
|
|
Former Executive Vice President, Chief Financial Officer and Treasurer
|
|
2012
|
|
375,000
|
|
|
112,500
|
|
|
666,080
|
|
|
165,020
|
|
|
—
|
|
|
7,500
|
|
|
1,326,100
|
|
|
|
2011
|
|
373,531
|
|
|
—
|
|
|
311,364
|
|
|
307,508
|
|
|
324,433
|
|
|
7,350
|
|
|
1,324,186
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Jeffrey A. Beck (7)
|
|
2013
|
|
427,693
|
|
|
—
|
|
|
561,784
|
|
(8)
|
140,740
|
|
(8)
|
—
|
|
|
744,840
|
|
(9)
|
1,875,057
|
|
|
Former Chief Operating Officer
|
|
2012
|
|
403,077
|
|
|
104,200
|
|
|
1,255,942
|
|
|
310,322
|
|
|
—
|
|
|
7,500
|
|
|
2,081,041
|
|
|
|
2011
|
|
347,960
|
|
|
—
|
|
|
225,990
|
|
|
223,642
|
|
|
302,029
|
|
|
7,350
|
|
|
1,106,971
|
|
|
|
(1)
|
Represents salary earned in the fiscal years presented, which covered 52 weeks for fiscal years 2013, 2012 and 2011.
|
|
(2)
|
Represents the aggregate grant date fair value for stock and option awards granted in the fiscal years ended December 28, 2013, December 29, 2012 and December 31, 2011, as appropriate, in accordance with FASB ASC Topic 718. See the information appearing in note 9 to our consolidated financial statements included as part of our Annual Report on Form 10-K for the fiscal year ended December 28, 2013 for certain assumptions made in the valuation of stock and option awards.
|
|
(3)
|
Represents amounts paid in 2014 under the Company's Senior Executive Incentive Compensation Plan for performance in the fiscal year ended December 28, 2013.
|
|
(4)
|
Includes 401(k) matching contributions for each of our named executive officers. Excludes medical, group life insurance and certain other benefits received by the named executive officers that are available generally to all of our salaried employees and certain perquisites and other personal benefits received by the named executive officers which do not exceed $10,000 in the aggregate.
|
|
(5)
|
Ms. Dean was appointed Executive Vice President, Chief Financial Officer and Treasurer on April 5, 2013.
|
|
(6)
|
Mr. Leahy resigned as Executive Vice President, Chief Financial Officer and Treasurer effective April 5, 2013. The amount in the Salary column for Mr. Leahy represents base salary paid to Mr. Leahy from December 30, 2012 through April 5, 2013.
|
|
(7)
|
Mr. Beck resigned as Chief Operating Officer effective November 25, 2013 and his employment with the Company terminated on December 27, 2013.
|
|
(8)
|
Pursuant to the terms of a Separation Agreement between the Company and Mr. Beck, dated November 25, 2013 (the “Separation Agreement”), the Company accelerated the vesting of 9,219 shares of common stock underlying Mr. Beck’s stock options and 21,207 restricted stock units held by Mr. Beck.
|
|
(9)
|
Includes cash severance payments of $215,000, health, dental and vision insurance contribution benefits of $9,816, vacation payout of $6,049, 401(k) matching contribution of $7,650 and a cash payment of $506,325, which is equal to the amount that Mr. Beck would have received under the Company’s Senior Executive Incentive Compensation Plan if he had remained employed by the Company through the date on which amounts were paid to the executive officers under such plan, pursuant to the Separation Agreement.
|
|
|
|
|
|
Estimated Future Payouts Under
Non-Equity Incentive Plan Awards(1) |
|
All Other
Stock
Awards:
Number
of Shares of Stock or Units (#)(2) |
|
All Other
Option
Awards:
Number of
Securities Underlying Options (#)(2) |
|
Exercise
or Base Price of Option Awards ($/Sh) |
|
Grant
Date Fair Value of Stock and Option Awards ($) |
|
||||||||||||
|
Name
|
|
Grant Date
|
|
Threshold
($) |
|
Target
($) |
|
Maximum
($) |
|
|
|||||||||||||||
|
Colin M. Angle
|
|
—
|
|
|
—
|
|
|
625,000
|
|
|
1,250,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
3/8/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
66,250
|
|
|
—
|
|
|
—
|
|
|
1,514,475
|
|
|
|
|
|
3/8/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
36,175
|
|
|
22.86
|
|
|
379,237
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Alison Dean
|
|
—
|
|
|
—
|
|
|
195,000
|
|
|
390,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
3/8/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,100
|
|
|
—
|
|
|
—
|
|
|
208,026
|
|
|
|
|
|
6/7/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14,800
|
|
|
—
|
|
|
—
|
|
|
513,116
|
|
|
|
|
|
3/8/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,975
|
|
|
22.86
|
|
|
52,155
|
|
|
|
|
|
6/7/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8,475
|
|
|
34.67
|
|
|
127,628
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Russell J. Campanello
|
|
—
|
|
|
—
|
|
|
195,000
|
|
|
390,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
3/8/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,825
|
|
|
—
|
|
|
—
|
|
|
270,319
|
|
|
|
|
|
3/8/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,450
|
|
|
22.86
|
|
|
67,618
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Paolo Pirjanian
|
|
—
|
|
|
—
|
|
|
195,000
|
|
|
390,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
3/8/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,825
|
|
|
—
|
|
|
—
|
|
|
270,319
|
|
|
|
|
|
3/8/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,450
|
|
|
22.86
|
|
|
67,618
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Glen D. Weinstein
|
|
—
|
|
|
—
|
|
|
201,000
|
|
|
402,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
3/8/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,825
|
|
|
—
|
|
|
—
|
|
|
270,319
|
|
|
|
|
|
3/8/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,450
|
|
|
22.86
|
|
|
67,618
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
John J. Leahy (3)
|
|
—
|
|
|
—
|
|
|
322,500
|
|
|
645,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Jeffrey A. Beck
|
|
—
|
|
|
—
|
|
|
322,500
|
|
|
645,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
3/8/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
24,575
|
|
|
—
|
|
|
—
|
|
|
561,784
|
|
(4)
|
|
|
|
3/8/2013
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,425
|
|
|
22.86
|
|
|
140,740
|
|
(5)
|
|
(1)
|
This reflects the threshold, target and maximum incentive cash payout levels established under our Senior Executive Incentive Compensation Plan. The actual amounts paid for fiscal year 2013 are disclosed in the "Non-Equity Incentive Plan Compensation" column of the Summary Compensation Table.
|
|
(2)
|
All stock awards and option awards were made pursuant to our 2005 Stock Option and Incentive Plan (the “2005 Plan”).
|
|
(3)
|
Represents the target and maximum amount of Mr. Leahy’s incentive payments under the Senior Executive Cash Incentive Compensation Plan. Mr. Leahy’s employment with the Company terminated on April 5, 2013 and, as a result, Mr. Leahy did not receive any cash incentive payment for the year ended December 28, 2013,
|
|
(4)
|
Pursuant to the terms of the Separation Agreement, the Company accelerated the vesting of 21,207 restricted stock units underlying this award.
|
|
(5)
|
Pursuant to the terms of the Separation Agreement, the Company accelerated the vesting of 9,219 shares of common stock underlying this stock option. This amount also includes the grant date fair value and the incremental fair value of the modified option.
|
|
|
|
Option Awards
|
|
Stock Awards
|
|||||||||||||||
|
Name
|
|
Grant Date
|
|
Number of
Securities Underlying Unexercised Options (#) Exercisable |
|
Number of
Securities Underlying Unexercised Options (#) Unexercisable(1) |
|
Option
Exercise Price ($) |
|
Option
Expiration Date |
|
Number of
Shares or Units of Stock That Have Not Vested (#)(2) |
|
Market Value of
Shares or Units of Stock That Have Not Vested ($)(3) |
|||||
|
Colin M. Angle
|
|
5/25/2007
|
|
21,333
|
|
|
—
|
|
|
16.03
|
|
|
5/25/2014
|
|
—
|
|
|
—
|
|
|
|
|
3/28/2008
|
|
26,000
|
|
|
—
|
|
|
17.13
|
|
|
3/28/2015
|
|
—
|
|
|
—
|
|
|
|
|
2/20/2009
|
|
73,829
|
|
|
—
|
|
|
7.76
|
|
|
2/20/2016
|
|
—
|
|
|
—
|
|
|
|
|
4/2/2010
|
|
99,707
|
|
|
14,243
|
|
|
14.52
|
|
|
4/2/2017
|
|
7,562
|
|
|
267,770
|
|
|
|
|
4/1/2011
|
|
28,250
|
|
|
16,950
|
|
|
33.48
|
|
|
4/1/2018
|
|
11,400
|
|
|
403,674
|
|
|
|
|
3/9/2012
|
|
17,862
|
|
|
22,963
|
|
|
26.59
|
|
|
3/9/2019
|
|
60,937
|
|
|
2,157,779
|
|
|
|
|
3/8/2013
|
|
—
|
|
|
36,175
|
|
|
22.86
|
|
|
3/8/2020
|
|
66,250
|
|
|
2,345,913
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Alison Dean
|
|
7/27/2007
|
|
416
|
|
|
—
|
|
|
18.74
|
|
|
7/27/2014
|
|
—
|
|
|
—
|
|
|
|
|
7/25/2008
|
|
1,873
|
|
|
—
|
|
|
14.09
|
|
|
7/25/2015
|
|
—
|
|
|
—
|
|
|
|
|
4/2/2010
|
|
9,625
|
|
|
1,375
|
|
|
14.52
|
|
|
4/2/2017
|
|
725
|
|
|
25,672
|
|
|
|
|
4/1/2011
|
|
4,610
|
|
|
2,765
|
|
|
33.48
|
|
|
4/1/2018
|
|
1,862
|
|
|
65,933
|
|
|
|
|
3/9/2012
|
|
2,068
|
|
|
2,657
|
|
|
26.59
|
|
|
3/9/2019
|
|
7,050
|
|
|
249,641
|
|
|
|
|
3/8/2013
|
|
—
|
|
|
4,975
|
|
|
22.86
|
|
|
3/8/2020
|
|
9,100
|
|
|
322,231
|
|
|
|
|
6/7/2013
|
|
—
|
|
|
8,475
|
|
|
34.67
|
|
|
6/7/2020
|
|
14,800
|
|
|
524,068
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Russell J. Campanello
|
|
12/30/2010
|
|
28,750
|
|
|
31,250
|
|
|
24.53
|
|
|
12/30/2017
|
|
17,500
|
|
|
619,675
|
|
|
|
|
3/9/2012
|
|
2,406
|
|
|
3,094
|
|
|
26.59
|
|
|
3/9/2019
|
|
15,712
|
|
|
556,362
|
|
|
|
|
3/8/2013
|
|
—
|
|
|
6,450
|
|
|
22.86
|
|
|
3/8/2020
|
|
11,825
|
|
|
418,723
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Paolo Pirjanian
|
|
10/1/2012
|
(4)
|
9,306
|
|
|
17,993
|
|
|
4.81
|
|
|
6/11/2022
|
|
—
|
|
|
—
|
|
|
|
|
10/1/2012
|
(4)
|
2,212
|
|
|
1,622
|
|
|
3.54
|
|
|
5/6/2021
|
|
—
|
|
|
—
|
|
|
|
|
12/7/2012
|
|
25,000
|
|
|
75,000
|
|
|
18.47
|
|
|
12/7/2019
|
|
22,500
|
|
|
796,725
|
|
|
|
|
3/8/2013
|
|
—
|
|
|
6,450
|
|
|
22.86
|
|
|
3/8/2020
|
|
11,825
|
|
|
418,723
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Glen D. Weinstein
|
|
5/25/2007
|
|
3,500
|
|
|
—
|
|
|
16.03
|
|
|
5/25/2014
|
|
—
|
|
|
—
|
|
|
|
|
4/2/2010
|
|
20,825
|
|
|
2,975
|
|
|
14.52
|
|
|
4/2/2017
|
|
1,575
|
|
|
55,771
|
|
|
|
|
4/1/2011
|
|
7,110
|
|
|
4,265
|
|
|
33.48
|
|
|
4/1/2018
|
|
2,874
|
|
|
101,768
|
|
|
|
|
3/9/2012
|
|
2,549
|
|
|
3,276
|
|
|
26.59
|
|
|
3/9/2019
|
|
8,681
|
|
|
307,394
|
|
|
|
|
9/7/2012
|
|
1,727
|
|
|
3,798
|
|
|
25.99
|
|
|
9/7/2019
|
|
8,231
|
|
|
291,460
|
|
|
|
|
3/8/2013
|
|
—
|
|
|
6,450
|
|
|
22.86
|
|
|
3/8/2020
|
|
11,825
|
|
|
418,723
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Jeffrey A. Beck (5)
|
|
4/2/2010
|
|
4,031
|
|
|
—
|
|
|
14.52
|
|
|
4/2/2017
|
|
—
|
|
|
—
|
|
|
|
|
4/1/2011
|
|
3,351
|
|
|
—
|
|
|
33.48
|
|
|
4/1/2018
|
|
—
|
|
|
—
|
|
|
|
|
3/9/2012
|
|
2,850
|
|
|
—
|
|
|
26.59
|
|
|
3/9/2019
|
|
—
|
|
|
—
|
|
|
|
|
9/7/2012
|
|
3,150
|
|
|
—
|
|
|
25.99
|
|
|
3/9/2019
|
|
—
|
|
|
—
|
|
|
|
|
3/8/2013
|
|
3,357
|
|
|
—
|
|
|
22.86
|
|
|
3/8/2020
|
|
—
|
|
|
—
|
|
|
(1)
|
Stock option grants vest over a four-year period, at a rate of twenty-five percent (25%) on the first anniversary of the grant, and the remainder in equal quarterly installments thereafter.
|
|
(2)
|
Restricted stock unit awards vest over a four-year period, at a rate of twenty-five percent (25%) on each anniversary of the grant.
|
|
(3)
|
Amounts disclosed in this column were calculated based on the fair market value of our common stock.
|
|
(4)
|
The stock options granted to Dr. Pirjanian on October 1, 2012 were granted as replacement awards for unvested stock options that Dr. Pirjanian held in Evolution Robotics, Inc. as of the date that the Company acquired Evolution Robotics, Inc.
|
|
(5)
|
Mr. Beck’s employment with the Company terminated on December 27, 2013 and pursuant to the Separation Agreement, the vesting of 9,219 shares of common stock underlying Mr. Beck’s stock options was accelerated and the remaining shares underlying his unvested stock options were forfeited.
|
|
|
|
Option Awards
|
|
Stock Awards
|
||||||
|
Name
|
|
Shares
Acquired on Exercise(#) |
|
Value
Realized on Exercise($)(1) |
|
Number of Shares
Acquired on Vesting(#) |
|
Value
Realized on Vesting($)(2) |
||
|
Colin M. Angle
|
|
—
|
|
|
—
|
|
|
42,434
|
|
986,880
|
|
Alison Dean
|
|
14,058
|
|
|
132,168
|
|
|
4,006
|
|
95,746
|
|
Russell J. Campanello
|
|
40,000
|
|
|
437,385
|
|
|
13,988
|
|
283,140
|
|
Paolo Pirjanian
|
|
—
|
|
|
—
|
|
|
7,500
|
|
230,400
|
|
Glen D. Weinstein
|
|
57,625
|
|
|
1,084,015
|
|
|
11,486
|
|
298,605
|
|
John L. Leahy
|
|
73,190
|
|
|
903,482
|
|
|
13,554
|
|
320,325
|
|
Jeffrey A. Beck (3)
|
|
67,638
|
|
|
899,036
|
|
|
45,020
|
|
1,347,669
|
|
(1)
|
Amounts disclosed in this column were calculated based on the difference between the fair market value of our common stock on the date of exercise and the exercise price of the options in accordance with regulations promulgated under the Exchange Act.
|
|
(2)
|
Amounts disclosed in this column were calculated based on the fair market value of the shares on the date of settlement upon vesting.
|
|
(3)
|
Pursuant to the Separation Agreement, the vesting of 9,219 shares of common stock underlying stock options and 21,207 shares of common stock underlying restricted stock units held by Mr. Beck were accelerated and the remaining shares underlying his stock options and restricted stock units were forfeited. The vested shares underlying his stock options were exercisable for a period of 90 days after December 27, 2013. Mr. Beck exercised 16,739 shares on January 7, 2014.
|
|
Name
|
|
Base
Salary ($) |
|
Continuation of
Health Plan Premium Payments ($) |
|
Total ($)
|
|
Colin M. Angle
|
|
312,500
|
|
9,816
|
|
322,316
|
|
Alison Dean
|
|
162,500
|
|
8,759
|
|
171,259
|
|
Russell J. Campanello
|
|
162,500
|
|
9,816
|
|
172,316
|
|
Paolo Pirjanian
|
|
162,500
|
|
9,816
|
|
172,316
|
|
Glen D. Weinstein
|
|
167,500
|
|
8,759
|
|
176,259
|
|
John J. Leahy (1)
|
|
215,000
|
|
9,816
|
|
224,816
|
|
Jeffrey A. Beck (2)
|
|
215,000
|
|
9,816
|
|
224,816
|
|
(1)
|
John J. Leahy resigned as Executive Vice President, Chief Financial Officer and Treasurer effective April 5, 2013. Accordingly, Mr. Leahy is not entitled to the amounts set forth in the above table.
|
|
(2)
|
Jeffrey A. Beck resigned as Chief Operating Officer effective November 25, 2013 and his employment with the Company terminated on December 27, 2013. The amounts set forth in the table above represent certain amounts paid to Mr. Beck under the terms of the Separation Agreement in connection with his termination. In addition, under the terms of the Separation Agreement, Mr. Beck received $506,325, which is equivalent to the amount that he would have received under the Company’s Senior Executive Cash Incentive Compensation Plan if he had remained employed with the Company through the date on which amounts were paid to the executive officers under such plan as well as partial acceleration of the vesting of unvested equity awards granted to Mr. Beck under the 2005 Plan. The intrinsic value of the stock options and restricted stock units held by Mr. Beck that vested in connection with his termination of employment was $224,621 and $750,940, respectively.
|
|
Name
|
|
Base
Salary ($) |
|
Bonus
($) |
|
Continuation
of Health Plan Premium Payments ($) |
|
Market
Value of Stock Options ($) |
|
Market
Value of Restricted Stock and Restricted Stock Units ($) |
|
Total
($) |
||||||
|
Colin M. Angle
|
|
1,250,000
|
|
|
1,250,000
|
|
|
39,265
|
|
|
986,780
|
|
|
5,175,136
|
|
|
8,701,181
|
|
|
Alison Dean
|
|
650,000
|
|
|
390,000
|
|
|
35,036
|
|
|
126,203
|
|
|
1,187,545
|
|
|
2,388,784
|
|
|
Russell J. Campanello
|
|
650,000
|
|
|
390,000
|
|
|
39,265
|
|
|
448,237
|
|
|
1,594,760
|
|
|
3,122,262
|
|
|
Paolo Pirjanian
|
|
650,000
|
|
|
390,000
|
|
|
39,265
|
|
|
1,953,726
|
|
|
1,215,448
|
|
|
4,248,439
|
|
|
Glen D. Weinstein
|
|
670,000
|
|
|
402,000
|
|
|
35,036
|
|
|
215,998
|
|
|
1,175,116
|
|
|
2,498,150
|
|
|
John J. Leahy (1)
|
|
860,000
|
|
|
645,000
|
|
|
39,265
|
|
|
—
|
|
|
—
|
|
|
1,544,265
|
|
|
Jeffrey A. Beck (2)
|
|
860,000
|
|
|
645,000
|
|
|
39,265
|
|
|
—
|
|
|
—
|
|
|
1,544,265
|
|
|
(1)
|
John J. Leahy resigned as Executive Vice President, Chief Financial Officer and Treasurer effective April 5, 2013. Accordingly, Mr. Leahy is not entitled to the amounts set forth in the above table.
|
|
(2)
|
Jeffrey A. Beck resigned as Chief Operating Officer effective November 25, 2013. Accordingly, Mr. Beck is not entitled to the amounts set forth in the above table.
The amounts actually paid to Mr. Beck in connection with the termination of his employment are described above.
|
|
|
|
|
Annual retainer for Board membership
|
$35,000
|
|
Annual retainer for lead independent director
|
$7,000
|
|
Audit Committee
|
|
|
Annual retainer for committee membership
|
$10,000
|
|
Additional retainer for committee chair
|
$10,000
|
|
Compensation Committee
|
|
|
Annual retainer for committee membership
|
$7,500
|
|
Additional retainer for committee chair
|
$7,500
|
|
Nominating and Corporate Governance Committee
|
|
|
Annual retainer for committee membership
|
$5,000
|
|
Additional retainer for committee chair
|
$5,000
|
|
|
Upon initial election to the board of directors, a non-employee director receives a one-time grant of restricted stock units having a fair market value of $220,000, measured at the end of the tenth week of the fiscal quarter in which the director was elected, which vests over a four-year period at a rate of twenty-five percent (25%) on each of the first four anniversaries of the grant.
|
|
|
At the end of the tenth week of the fiscal quarter in which our annual meeting of stockholders occurs, each non-employee director receives a grant of restricted stock units having a fair market value of $110,000, which vests on the earlier of the date of the first anniversary of such grant or the date of the first annual meeting of stockholders following the date of grant.
|
|
Name
|
|
Fees Earned or
Paid in Cash ($) |
|
Stock Awards
($)(3) |
|
Total ($)
|
|||
|
Ronald Chwang, Ph.D.
|
|
42,500
|
|
|
109,973
|
|
|
152,473
|
|
|
Gail Deegan
|
|
45,000
|
|
|
109,973
|
|
|
154,973
|
|
|
Deborah G. Ellinger
|
|
42,500
|
|
|
109,973
|
|
|
152,473
|
|
|
Jacques S. Gansler, Ph.D.
|
|
40,000
|
|
|
109,973
|
|
|
149,973
|
|
|
Andrea Geisser
|
|
55,000
|
|
|
109,973
|
|
|
164,973
|
|
|
Paul J. Kern, Gen. U.S. Army (ret.)
|
|
45,000
|
|
|
109,973
|
|
|
154,973
|
|
|
George C. McNamee
|
|
60,750
|
|
|
109,973
|
|
|
170,723
|
|
|
Peter T. Meekin (2)
|
|
10,000
|
|
|
—
|
|
|
10,000
|
|
|
Paul L. Sagan (1)
|
|
45,000
|
|
|
109,973
|
|
|
154,973
|
|
|
(1)
|
Mr. Sagan deferred all of his 2013 cash compensation pursuant to our Non-employee Directors’ Deferred Compensation Program under which he received stock units in lieu of cash.
|
|
(2)
|
Mr. Meekin did not stand for re-election at the 2013 annual meeting of stockholders.
|
|
(3)
|
Represents the grant date fair value of restricted stock units awarded in the fiscal year ended December 28, 2013 in accordance with FASB ASC Topic 718. The grant date fair value is the fair market value of our common stock on the date of grant multiplied by the number of shares of common stock underlying such restricted stock unit award.
|
|
Name
|
|
Number of
Securities Underlying Unexercised Options |
|
Number of
Unvested Restricted Stock Units |
||
|
Ronald Chwang, Ph.D.
|
|
40,000
|
|
|
3,172
|
|
|
Gail Deegan
|
|
—
|
|
|
6,230
|
|
|
Deborah G. Ellinger
|
|
—
|
|
|
8,699
|
|
|
Jacques S. Gansler, Ph.D.
|
|
—
|
|
|
3,172
|
|
|
Andrea Geisser
|
|
50,000
|
|
|
3,172
|
|
|
Paul J. Kern, Gen. U.S. Army (ret.)
|
|
70,000
|
|
|
3,172
|
|
|
George C. McNamee
|
|
80,000
|
|
|
3,172
|
|
|
Paul L. Sagan
|
|
25,000
|
|
|
3,172
|
|
|
|
|
2013
|
|
2012
|
||||
|
Audit Fees
|
|
$
|
895,013
|
|
|
$
|
819,724
|
|
|
Audit-Related Fees
|
|
38,499
|
|
|
53,775
|
|
||
|
Tax Fees
|
|
6,900
|
|
|
39,500
|
|
||
|
All Other Fees
|
|
3,394
|
|
|
3,394
|
|
||
|
Total
|
|
$
|
943,806
|
|
|
$
|
916,393
|
|
|
|
|
|
|
|
||||
|
|
|
For the twelve months ended
|
||||||
|
|
|
December 28,
2013 |
|
December 29,
2012 |
||||
|
Net income
|
|
$
|
27,641
|
|
|
$
|
17,297
|
|
|
Interest income, net
|
|
(660)
|
|
|
(1,016)
|
|
||
|
Income tax expense
|
|
4,774
|
|
|
8,310
|
|
||
|
Depreciation
|
|
8,077
|
|
|
9,898
|
|
||
|
Amortization
|
|
4,092
|
|
|
1,774
|
|
||
|
EBITDA
|
|
43,924
|
|
|
36,263
|
|
||
|
Stock-based compensation expense
|
|
13,409
|
|
|
10,983
|
|
||
|
Merger and acquisition expense
|
|
400
|
|
|
1,404
|
|
||
|
Net intellectual property litigation expense
|
|
1,202
|
|
|
155
|
|
||
|
Restructuring expense
|
|
3,296
|
|
|
3,679
|
|
||
|
Adjusted EBITDA
|
|
$
|
62,231
|
|
|
$
|
52,484
|
|
|
|
|
|
|
|
||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|